SCHEMBL27706593

SCHEMBL27706593

Cc1ccc(C(=O)/C=C/c2ccccc2)cc1C(=O)Nc1cnc2[nH]c(-c3ccccc3)nc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ BTK Q06187 2/20 0.43
▸ ABL1 P00519 1/20 0.40
▸ SRC P12931 1/20 0.40
▸ KIT P10721 2/20 0.40
▸ NR2E3 Q9Y5X4 1/20 0.40
▸ BLK P51451 1/20 0.39
▸ MET P08581 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ ABCG2 Q9UNQ0 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ CYP1B1 Q16678 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1136433 0.88 BTK (0.57) MAPTALDH1A1LMNAKDM4EHPGD
SCHEMBL1136434 0.88 BTK (0.57) MAPTALDH1A1LMNAKDM4EHPGD
SCHEMBL1136423 0.85 CHEK2 (0.52) MAPTALDH1A1LMNAKDM4EHPGD
SCHEMBL27755013 0.84 BTK (0.45) MAPTALDH1A1LMNAHPGDHTT
SCHEMBL1136425 0.83 BTK (0.52) MAPTALDH1A1LMNAKDM4EHPGD
SCHEMBL1136426 0.83 BTK (0.52) MAPTALDH1A1LMNAKDM4EHPGD
SCHEMBL1136409 0.83 BLK (0.57) MAPTALDH1A1LMNAKDM4EHPGD
SCHEMBL1136378 0.82 MMP2 (0.53) MAPTALDH1A1LMNAKDM4EHPGD
SCHEMBL1136400 0.82 BTK (0.53) BTKRAB9A
SCHEMBL1136399 0.82 BTK (0.53) BTKRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101208338-B Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents HOFFMANN LA ROCHE 2010-12-29 — — CN claimed
CN-101208338-A Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents HOFFMANN LA ROCHE (CH) 2008-06-25 — — CN claimed
CN-101208338-B Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents HOFFMANN LA ROCHE 2010-12-29 — — CN disclosed
CN-101208338-A Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents HOFFMANN LA ROCHE (CH) 2008-06-25 — — CN disclosed
Send feedback